መነሻ › የዩዊንግ ሳርኮማ › ማሳቹሴትስ
በማሳቹሴትስ ለየዩዊንግ ሳርኮማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለየዩዊንግ ሳርኮማ የሚደረጉ 6 ጥናቶች በማሳቹሴትስ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በማሳቹሴትስ ውስጥ ያሉ ከተሞች
Official study text (English)
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
- Dana Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 2 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07297979Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Dana-Farber Cancer Institute ( Site 1013), Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
6 Months – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06395103Lurbinectedin in FET-Fused Tumors
- Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 10 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT05918640Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
- Mass General Brigham Cancer Institute, Boston
- Dana Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 16 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁን 2026 · NCT07197554Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ12 እስከ 49 · ሁሉም ጾታዎች · የተሻሻለው በ19 ፌብሩ 2026 · NCT06709495ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።